IL57114A - 21-halogeno-corticoid-17-(alkyl carbonates),a process for their manufacture and pharmaceutical compositions for topical use containing them - Google Patents

21-halogeno-corticoid-17-(alkyl carbonates),a process for their manufacture and pharmaceutical compositions for topical use containing them

Info

Publication number
IL57114A
IL57114A IL57114A IL5711479A IL57114A IL 57114 A IL57114 A IL 57114A IL 57114 A IL57114 A IL 57114A IL 5711479 A IL5711479 A IL 5711479A IL 57114 A IL57114 A IL 57114A
Authority
IL
Israel
Prior art keywords
corticoid
halogeno
manufacture
pharmaceutical compositions
topical use
Prior art date
Application number
IL57114A
Other languages
English (en)
Other versions
IL57114A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL57114A0 publication Critical patent/IL57114A0/xx
Publication of IL57114A publication Critical patent/IL57114A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
IL57114A 1978-04-25 1979-04-23 21-halogeno-corticoid-17-(alkyl carbonates),a process for their manufacture and pharmaceutical compositions for topical use containing them IL57114A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782817988 DE2817988A1 (de) 1978-04-25 1978-04-25 Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IL57114A0 IL57114A0 (en) 1979-07-25
IL57114A true IL57114A (en) 1983-11-30

Family

ID=6037909

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57114A IL57114A (en) 1978-04-25 1979-04-23 21-halogeno-corticoid-17-(alkyl carbonates),a process for their manufacture and pharmaceutical compositions for topical use containing them

Country Status (19)

Country Link
US (1) US4377575A (xx)
EP (1) EP0004975B1 (xx)
JP (1) JPS54144357A (xx)
AR (1) AR226157A1 (xx)
AT (1) AT372094B (xx)
AU (1) AU529172B2 (xx)
CA (1) CA1130276A (xx)
DE (2) DE2817988A1 (xx)
DK (1) DK157880C (xx)
ES (2) ES479709A1 (xx)
FI (1) FI791307A (xx)
GR (1) GR72886B (xx)
HU (1) HU180788B (xx)
IE (1) IE48328B1 (xx)
IL (1) IL57114A (xx)
NO (1) NO791365L (xx)
NZ (1) NZ190256A (xx)
PT (1) PT69544A (xx)
ZA (1) ZA791941B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
JPS5835199A (ja) * 1981-08-26 1983-03-01 Mitsubishi Chem Ind Ltd モノヨ−ドステロイドおよびその製造法
JPS58103400A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk ６α−メチルプレドニゾロン誘導体
JPS6056997A (ja) * 1983-09-07 1985-04-02 Mitsubishi Chem Ind Ltd 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4328819A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
BRPI0113042B8 (pt) * 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
MX2010003698A (es) * 2007-10-04 2010-04-21 Astrazeneca Ab Compuestos de [3,2-c]pirazol esteroides con actividad glucocorticoide.
CA2707618A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Steroid derivatives acting as glucocorticosteroid receptor agonists
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1253831A (en) * 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
US4021459A (en) * 1975-08-14 1977-05-03 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AU529172B2 (en) 1983-05-26
PT69544A (de) 1979-05-01
EP0004975B1 (de) 1982-02-17
EP0004975A3 (en) 1979-11-14
EP0004975A2 (de) 1979-10-31
US4377575A (en) 1983-03-22
AR226157A1 (es) 1982-06-15
NO791365L (no) 1979-10-26
DK157880C (da) 1990-07-30
FI791307A (fi) 1979-10-26
IE48328B1 (en) 1984-12-12
DK157880B (da) 1990-02-26
JPS54144357A (en) 1979-11-10
IL57114A0 (en) 1979-07-25
ZA791941B (en) 1980-04-30
JPS6252759B2 (xx) 1987-11-06
ES479709A1 (es) 1980-08-16
IE790831L (en) 1979-10-25
AT372094B (de) 1983-08-25
ATA307479A (de) 1983-01-15
NZ190256A (en) 1981-03-16
ES488120A1 (es) 1980-09-16
CA1130276A (en) 1982-08-24
DK168579A (da) 1979-10-26
DE2962122D1 (en) 1982-03-25
HU180788B (en) 1983-04-29
GR72886B (xx) 1984-01-02
DE2817988A1 (de) 1979-11-08

Similar Documents

Publication Publication Date Title
IL57114A (en) 21-halogeno-corticoid-17-(alkyl carbonates),a process for their manufacture and pharmaceutical compositions for topical use containing them
GB2039738B (en) Inflammation - preventing pharmaceutical composition
DE2965763D1 (en) Tetrahydroisoquinoline compounds, process for preparing same and pharmaceutical compositions containing them
DE2960222D1 (en) Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them
JPS54132223A (en) Novel pharmaceutical composition
DE2964135D1 (en) Pharmaceutical compositions containing urea
ZA794240B (en) Novel dosage form
DE2963717D1 (en) Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
ZA791276B (en) N-oxacyclic-alkylpiperidyl-diazacompounds,process for their manufacture and pharmaceutical compositions containing them
PH15791A (en) Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines
GB2041219B (en) Topical pharmaceutical compositions containing thiazolidine-substituted corticosteroids
DE2961983D1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
DE2962567D1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
NZ192021A (en) Pharmaceutical compositions containing aryltrifluoroethanols
DE2964198D1 (en) Indanamine derivatives, process for their preparation and medicaments containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
DE2961285D1 (en) Frenolicin b, process for preparation thereof and pharmaceutical compositions containing it
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
JPS54154516A (en) Pharmaceutical composition
IL56696A (en) N1-glucofuranosid-6-yl-n3-nitroso-ureas,their production and pharmaceutical compositions containing them
JPS5527168A (en) Drug composition
DE2965483D1 (en) Phosphinegold(i)salts, process for their preparation and compositions containing them
DE2960205D1 (en) 4-hydroxy-2-benzimidazolin-thion derivatives, process for their preparation and medicaments containing them